Carlo Croce Named 2012 Distinguished University Professor
Carlo Croce’s research in the field of cancer genetics has quite literally transformed the manner in which cancers are diagnosed and treated, leading to better outcomes for patients.
His research has uncovered early genetic events that lead to leukemia, lymphoma and lung, nasopharyngeal, head and neck, esophageal, gastrointestinal and breast cancers.
More recently, he discovered the novel role of microRNAs in the genesis of various cancers — a dicovery that could lead to breakthroughs in other genetically based diseases such as Alzheimer’s, schizophrenia, immune system disorders and cardiovascular disease.
His work has earned him some of the most prestigious awards and recognition scientists can receive, among them his election to the Institute of Medicine of the National Academies and membership in the American Academy of Arts and Sciences. He is the seventh-most cited author in all of biology, according to Thomson Reuters Essential Science Indicators.
“Dr. Croce’s contributions to our understanding of the genetic and molecular underpinnings of cancer are monumental,” a colleague wrote in support of the nomination. He has been consistently pioneering, highly original and has shown an unfailing instinct for important problems that are solvable by the application of imaginative science.”
The Office of Academic Affairs and the Board of Trustees confers the permanent, honorific title of Distinguished University Professor to full professors who have exceptional records in teaching, research, scholarly work and service. Recipients are awarded a $30,000 one-time grant to support their work. Carlo Croce is the 46th professor to have received the title since it was first awarded in 1987.